DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
BMS-275183
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Tubulin stabiliser
BMS-275183
×
Maximum Phase:
2
First Approval:
None
UNII:
UQC681JJIV
Molecule Type:
Small molecule
Molecular Formula:
C43H59NO16
Molecular Weight:
845.94
AlogP:
3.72
PSA:
239.75
HBD:
4.0
HBA:
#RotB:
8.0
Source:
MITOGLITAZONE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Diabetes Mellitus, Type 2
Unknown
MITOGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
29I7RP18RG
Molecule Type:
Small molecule
Molecular Formula:
C19H18N2O4S
Molecular Weight:
370.43
AlogP:
2.8
PSA:
85.36
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BGC-20-1531 FREE BASE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BGC-20-1531 FREE BASE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H24N2O6S
Molecular Weight:
492.55
AlogP:
4.66
PSA:
107.73
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MARDEPODECT
2
Small molecule
Investigational
Unknown
Unknown
Huntington Disease; Schizophrenia
Phosphodiesterase 10A inhibitor
MARDEPODECT
×
Maximum Phase:
2
First Approval:
None
UNII:
R9Y8EY0G42
Molecule Type:
Small molecule
Molecular Formula:
C25H20N4O
Molecular Weight:
392.46
AlogP:
5.28
PSA:
52.83
HBD:
0.0
HBA:
#RotB:
5.0
Source:
RG-547
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase 1 inhibitor
RG-547
×
Maximum Phase:
2
First Approval:
None
UNII:
T61871RKRI
Molecule Type:
Small molecule
Molecular Formula:
C18H21F2N5O4S
Molecular Weight:
441.46
AlogP:
1.41
PSA:
127.51
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ELSUBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic
Tyrosine-protein kinase BTK inhibitor
ELSUBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
1487U1Q3IQ
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3O2
Molecular Weight:
297.36
AlogP:
2.16
PSA:
79.19
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FOSBRETABULIN
2
Small molecule
Investigational
Unknown
Unknown
Ovarian Neoplasms; Neoplasms; Neuroendocrine Tumors; Thyroid Neoplasms
Unknown
FOSBRETABULIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I5590ES2QZ
Molecule Type:
Small molecule
Molecular Formula:
C18H21O8P
Molecular Weight:
396.33
AlogP:
3.36
PSA:
103.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ACOZIBOROLE
2
Small molecule
Investigational
Unknown
Unknown
Trypanosomiasis; Trypanosomiasis, African
Cleavage and polyadenylation specificity factor subunit inhibitor
ACOZIBOROLE
×
Maximum Phase:
2
First Approval:
None
UNII:
2IOR2OO3GW
Molecule Type:
Small molecule
Molecular Formula:
C17H14BF4NO3
Molecular Weight:
367.11
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
7-METHYLXANTHINE
2
Small molecule
Investigational
Unknown
Unknown
Myopia
Unknown
7-METHYLXANTHINE
×
Maximum Phase:
2
First Approval:
None
UNII:
E9M81NJM6G
Molecule Type:
Small molecule
Molecular Formula:
C6H6N4O2
Molecular Weight:
166.14
AlogP:
-0.23
PSA:
84.06
HBD:
2.0
HBA:
#RotB:
0.0
Source:
DELPAZOLID
2
Small molecule
Investigational
Unknown
Unknown
Tuberculosis, Pulmonary
Bacterial 70S ribosome inhibitor
DELPAZOLID
×
Maximum Phase:
2
First Approval:
None
UNII:
43EP6XV33E
Molecule Type:
Small molecule
Molecular Formula:
C14H17FN4O3
Molecular Weight:
308.31
AlogP:
0.84
PSA:
68.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MOXAVERINE
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases; Ischemia
Unknown
MOXAVERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
P3P08Y1XJ4
Molecule Type:
Small molecule
Molecular Formula:
C20H21NO2
Molecular Weight:
307.39
AlogP:
4.41
PSA:
31.35
HBD:
0.0
HBA:
#RotB:
5.0
Source:
AZD0328
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
AZD0328
×
Maximum Phase:
2
First Approval:
None
UNII:
2B218X5QIY
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2O
Molecular Weight:
216.28
AlogP:
1.48
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ORTATAXEL
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Renal Cell; Glioblastoma; Kidney Neoplasms; Lung Neoplasms; Lymphoma
Unknown
ORTATAXEL
×
Maximum Phase:
2
First Approval:
None
UNII:
8H61Y4E29N
Molecule Type:
Small molecule
Molecular Formula:
C44H57NO17
Molecular Weight:
871.93
AlogP:
3.66
PSA:
245.82
HBD:
3.0
HBA:
#RotB:
10.0
Source:
RELMAPIRAZIN
2
Small molecule
Investigational
Unknown
Unknown
Blastic Plasmacytoid Dendritic Cell Neoplasm; Optical Imaging; Acute Kidney Injury; Renal Insufficiency, Chronic
Unknown
RELMAPIRAZIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Q3UQB8PQ6H
Molecule Type:
Small molecule
Molecular Formula:
C12H16N6O8
Molecular Weight:
372.29
AlogP:
-4.01
PSA:
251.08
HBD:
8.0
HBA:
#RotB:
8.0
Source:
BALICATIB
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee; Osteoporosis
Cathepsin K inhibitor
BALICATIB
×
Maximum Phase:
2
First Approval:
None
UNII:
E00MVC7O57
Molecule Type:
Small molecule
Molecular Formula:
C23H33N5O2
Molecular Weight:
411.55
AlogP:
2.29
PSA:
88.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LY-295501
2
Small molecule
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Unknown
LY-295501
×
Maximum Phase:
2
First Approval:
None
UNII:
240Y4YO0TN
Molecule Type:
Small molecule
Molecular Formula:
C15H12Cl2N2O4S
Molecular Weight:
387.24
AlogP:
3.44
PSA:
84.5
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PALMIDROL
2
Small molecule
Investigational
Unknown
Unknown
Opioid-Related Disorders; Bipolar Disorder; Chronic Pain; Mastocytosis; Severe Acute Respiratory Syndrome; Tourette Syndrome; Migraine Disorders
Unknown
PALMIDROL
×
Maximum Phase:
2
First Approval:
None
UNII:
6R8T1UDM3V
Molecule Type:
Small molecule
Molecular Formula:
C18H37NO2
Molecular Weight:
299.5
AlogP:
4.58
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
16.0
Source:
GOLOTIMOD
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic; Stomatitis
Unknown
GOLOTIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
637C487Y09
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O5
Molecular Weight:
333.34
AlogP:
0.47
PSA:
145.51
HBD:
5.0
HBA:
#RotB:
8.0
Source:
BI 44370 TA
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BI 44370 TA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
(+)-EPICATECHIN
2
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne; Prediabetic State; Friedreich Ataxia; Hypertension
Unknown
(+)-EPICATECHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
LD6B6TT8Q5
Molecule Type:
Small molecule
Molecular Formula:
C15H14O6
Molecular Weight:
290.27
AlogP:
1.55
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
CHOLESTEROL
2
Small molecule
Investigational
Unknown
Unknown
Asperger Syndrome; Autistic Disorder; Head and Neck Neoplasms; Porokeratosis; Smith-Lemli-Opitz Syndrome
Unknown
CHOLESTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
97C5T2UQ7J
Molecule Type:
Small molecule
Molecular Formula:
C27H46O
Molecular Weight:
386.66
AlogP:
7.39
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PIROMELATINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Sleep Initiation and Maintenance Disorders
Melatonin receptor agonist
PIROMELATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
S3UN2146K9
Molecule Type:
Small molecule
Molecular Formula:
C17H16N2O4
Molecular Weight:
312.33
AlogP:
2.1
PSA:
84.33
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SABARUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
SABARUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
XS499WOZ93
Molecule Type:
Small molecule
Molecular Formula:
C32H37NO13
Molecular Weight:
643.64
AlogP:
-0.13
PSA:
235.53
HBD:
7.0
HBA:
#RotB:
6.0
Source:
L 756423
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
L 756423
×
Maximum Phase:
2
First Approval:
None
UNII:
862SGU1BRL
Molecule Type:
Small molecule
Molecular Formula:
C39H48N4O5
Molecular Weight:
652.84
AlogP:
4.22
PSA:
118.28
HBD:
4.0
HBA:
#RotB:
11.0
Source:
DELEOBUVIR SODIUM
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
DELEOBUVIR SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
6X4T3L6431
Molecule Type:
Small molecule
Molecular Formula:
C34H32BrN6NaO3
Molecular Weight:
675.56
AlogP:
6.85
PSA:
114.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TOREFORANT
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Histamine H4 receptor antagonist
TOREFORANT
×
Maximum Phase:
2
First Approval:
None
UNII:
U6LA7G393X
Molecule Type:
Small molecule
Molecular Formula:
C23H32N6
Molecular Weight:
392.55
AlogP:
4.48
PSA:
69.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PILARALISIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Lymphoma; Neoplasms; Endometrial Neoplasms
PI3-kinase class I inhibitor
PILARALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
60ES45KTMK
Molecule Type:
Small molecule
Molecular Formula:
C25H25ClN6O4S
Molecular Weight:
541.03
AlogP:
4.51
PSA:
148.33
HBD:
4.0
HBA:
#RotB:
8.0
Source:
ROLIPRAM
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Major; Huntington Disease; Nervous System Diseases; Multiple Sclerosis
Phosphodiesterase 4 inhibitor
ROLIPRAM
×
Maximum Phase:
2
First Approval:
None
UNII:
K676NL63N7
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO3
Molecular Weight:
275.35
AlogP:
2.62
PSA:
47.56
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SAR-113945
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis; Osteoarthritis, Knee
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
SAR-113945
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LT-NS001
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LT-NS001
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOFIMILAST
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Phosphodiesterase 4 inhibitor
TOFIMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
5D7022962A
Molecule Type:
Small molecule
Molecular Formula:
C18H21N5S
Molecular Weight:
339.47
AlogP:
4.1
PSA:
48.53
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LOMETREXOL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Lung Neoplasms
Unknown
LOMETREXOL
×
Maximum Phase:
2
First Approval:
None
UNII:
6P3AVY8A7Q
Molecule Type:
Small molecule
Molecular Formula:
C21H25N5O6
Molecular Weight:
443.46
AlogP:
0.62
PSA:
187.5
HBD:
6.0
HBA:
#RotB:
9.0
Source:
CILUPREVIR
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatitis C virus serine protease, NS3/NS4A inhibitor
CILUPREVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
75C8DU40T0
Molecule Type:
Small molecule
Molecular Formula:
C40H50N6O8S
Molecular Weight:
774.94
AlogP:
6.05
PSA:
181.31
HBD:
4.0
HBA:
#RotB:
9.0
Source:
KP-1461
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
DNA disrupting agent
KP-1461
×
Maximum Phase:
2
First Approval:
None
UNII:
3PEN569TJP
Molecule Type:
Small molecule
Molecular Formula:
C16H28N4O6
Molecular Weight:
372.42
AlogP:
0.49
PSA:
132.72
HBD:
4.0
HBA:
#RotB:
8.0
Source:
LFF-571
2
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections
Elongation factor Tu inhibitor
LFF-571
×
Maximum Phase:
2
First Approval:
None
UNII:
W7AUL2R95Z
Molecule Type:
Small molecule
Molecular Formula:
C60H63N13O13S6
Molecular Weight:
1366.64
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
119
120
121
122
123
124
125
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA